Double-Blind Study Management and IRT Solutions

This document is a technical report detailing the complexities involved in managing a double-blind clinical study for a biotechnology company. The study required maintaining the blind amidst various treatment and visit complexities, including multiple drug types and administration routes. The investigational product was an intravenous injection, while the standard of care included an oral therapy with an option for IV. The report outlines how the study team managed these complexities through a robust Interactive Response Technology (IRT) system, which provided real-time flexibility and control over study operations. Key features of the IRT included unblinded and blinded accountability functions, dynamic dose management, and tracking of dispensation scenarios. The IRT allowed for seamless transitions between different treatment arms and visit schedules while preserving data integrity and minimizing disruptions. The report concludes with the effectiveness of the IRT in enhancing study management and reducing delays in trial operations.